TIME TO RETHINK: The old discussions about reporting HIV infection must be reviewed in light of a changing epidemic, says CDC's John Ward. As the AIDS epidemic enters a new phase of changing demographics and combination drug therapy, support is mounting for a national system of HIV case reporting. Even some civil rights activists who previously opposed HIV reporting now are admitting the need for it to help contain the elusive disease. However, the long-debated question of whether HIV-positive
 TIME TO RETHINK: The old discussions about reporting HIV infection must be reviewed in light of a changing epidemic, says CDC's John Ward. |
"We're at a turning point of this epidemic," notes John Ward, chief of HIV/AIDS surveillance in the Atlanta-based Centers for Disease Control and Prevention (CDC). "After 16 years, for the first time we're beginning to change, in a profound way, how we monitor it. Because of that, all the old ...
Add The Scientist as a preferred Google source to see more of our trusted coverage.
Miles away from the closest ocean, marine microbes thrive in the red ice and mud around Blood Falls, offering clues to microbial adaptation and past climate events.
View this Issue
Explore how blood-based biomarkers perform across Alzheimer’s disease stages, including AIBL Study findings comparing p-Tau217 and other markers against amyloid-beta and tau PET reference standards.
Learn how microvolume UV/Vis and DLS can accelerate, automate, and streamline protein developability screening while reducing sample requirements.
Assess protein sample purity and homogeneity in minutes with mass photometry using only nanograms of sample.
Explore how super-resolution microscopy enables particle-level characterization of lipid nanoparticle composition, cargo loading, heterogeneity, and stability, providing complementary insights for formulation development and optimization.
The placements follow the commercial launch of Pyxa at the Advances in Genome Biology and Technology (AGBT) meeting in February 2026 and mark the company's transition from Early Access into global commercial availability.
The CellRaft AIR streamlines antibody discovery with imaging, functional screening, and gentle isolation of viable single B cells and hybridomas, helping verify monoclonality and identify high producing clones faster.
Load plasma directly into prefilled cartridges, no pretreatment, no ethanol. Under 30 minutes of instrument run time, up to 48 samples in parallel, with a high-throughput format also available.
Two Paige tools, powered by the Virchow pathology foundation model, are now available within a single image management workspace for oncology research.
